1. OS05.9.A Short-term fasting in glioma patients - Analysis of diet diaries and metabolic parameters of the ERGO2 trial. (9th September 2021) Authors: Voss, M; Wenger, K J; von Mettenheim, N; Bojunga, J; Vetter, M; Diehl, B; Gerlach, R; Ronellenfitsch, M W; Franz, K; Harter, P N; Hattingen, E; Steinbach, J P; Rödel, C; Rieger, J Journal: Neuro-oncology Issue: Volume 23: Supplement 2 (2021) Page Start: ii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS6.5 ERGO2: A prospective randomized trial of a 9-day schedule of calorically restricted ketogenic diet and fasting or standard diet in addition to re-irradiation for malignant glioma. (6th September 2019) Authors: Voss, M; Wagner, M; von Mettenheim, N; Harter, P N; Wenger, K; Franz, K; Bojunga, J; Gerlach, R; Glatzel, M; Paulsen, F; Hattingen, E; Baehr, O; Ronellenfitsch, M W; Fokas, E; Imhoff, D; Steinbach, J P; Rödel, C; Rieger, J Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗